Target intelligence / Profile preview

GATOR2 complex (GATOR2)

Target
GATOR2
Molecular classification
Multiprotein complex, Other
01

Overview

The GATOR2 complex (GAP activity towards Rags 2) is a highly conserved, pentameric multiprotein assembly consisting of five subunits: MIOS, WDR24, WDR59, SEH1L, and SEC13. It serves as a critical positive regulator of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway by opposing the inhibitory activity of the GATOR1 complex in response to amino acid availability. Under nutrient-depleted conditions, GATOR2 is bound and inhibited by amino acid sensors such as Sestrin2 (for leucine) and CASTOR1 (for arginine). Upon amino acid sufficiency, these sensors dissociate, allowing GATOR2 to inhibit GATOR1, which subsequently promotes the lysosomal translocation and activation of mTORC1.

Beyond its role in mTORC1 activation, GATOR2 has been shown to regulate lysosomal-autophagic function and stabilize MiT/TFE transcription factors independently of mTORC1. Dysregulation of GATOR2 is implicated in various human pathologies, including cancer (such as PAX3-FOXO1-positive rhabdomyosarcoma, pancreatic ductal adenocarcinoma, and renal cell carcinoma), neurodegenerative diseases like Huntington's disease, and myelination defects. Consequently, GATOR2 represents an attractive therapeutic target, with small molecules like NV-5297 and NV-5138 designed to modulate its interaction with Sestrin2 to activate mTORC1, and other experimental inhibitors like Mi3 and Tanshinone IIA targeting its subunits to suppress tumor growth and induce autophagy.

Other names
GAP activity towards Rags 2 complexSeh1 Associated Complex Activates TORC1SEACATGATOR subcomplex 2
02

Mechanism of action

Modulation of the Sestrin2-GATOR2 interaction to activate mTORC1, or direct inhibition of GATOR2 subunits (such as MIOS) to suppress mTORC1 activity and induce autophagy.

03

Biological functions

Signal transductionCell proliferationAutophagyOther
04

Disease associations

CancerNeurodegenerative diseaseOther
05

Safety considerations

mTORC1 hyperactivation-associated metabolic dysregulationImmunosuppressionMyelination defectsLysosomal dysfunction
06

Interacting drugs

NV-5297

3 more in the full profile.

07

Biomarkers

Phospho-p70S6K1Phospho-RPS6Phospho-4EBP1PAX3-FOXO1 fusion status

Beyond the preview

Go deeper on GATOR2 complex (GATOR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GATOR2 complex (GATOR2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call